← Back to guidelines
Anesthesiology6 papers

Acute vascular insufficiency of intestine

Last edited: 50 min ago

Overview

Acute vascular insufficiency of the intestine, often resulting from inadequate perfusion due to conditions like hypothermic circulatory arrest or severe systemic hypoperfusion, leads to significant mucosal injury and can rapidly progress to multi-organ dysfunction if not promptly addressed. This condition primarily affects patients undergoing complex surgical procedures, particularly those involving deep hypothermic circulatory arrest, as well as critically ill patients with shock states. Recognizing and managing this acute complication is crucial in surgical and intensive care settings to prevent severe morbidity and mortality. Early intervention can significantly improve patient outcomes, underscoring its importance in day-to-day clinical practice 12.

Pathophysiology

Acute vascular insufficiency of the intestine initiates with a reduction in blood flow, leading to ischemia in the intestinal mucosa. This ischemia triggers a cascade of cellular events, including ATP depletion, activation of inflammatory pathways, and oxidative stress. The initial ischemic insult damages the microvasculature and epithelial barrier, resulting in mucosal edema, villous blunting, and increased permeability 1. During reperfusion, further injury occurs due to the influx of inflammatory cells and the release of reactive oxygen species, exacerbating tissue damage 2. Molecularly, the expression of protective factors like Cold-inducible RNA-binding protein (CIRBP) plays a crucial role in mitigating these effects; its absence significantly worsens intestinal barrier integrity and function 2. Additionally, hemodynamic factors such as shear stress influence intestinal function, with alterations in blood flow impacting glucose uptake and potentially exacerbating metabolic disturbances 4.

Epidemiology

The incidence of acute vascular insufficiency of the intestine is most commonly observed in high-risk surgical populations, particularly those undergoing complex cardiac surgeries involving deep hypothermic circulatory arrest. Specific incidence rates are not widely reported, but the condition is recognized as a significant complication in these settings. Age, pre-existing cardiovascular disease, and prolonged periods of circulatory arrest are notable risk factors. Geographic variations are less documented, but trends suggest an increased awareness and reporting in developed countries with advanced surgical capabilities 12.

Clinical Presentation

Patients with acute vascular insufficiency of the intestine may present with nonspecific symptoms initially, including abdominal pain, nausea, and vomiting. More specific signs include bloody stools (indicative of mucosal damage), fever, and signs of systemic inflammatory response syndrome (SIRS). Red-flag features include rapid deterioration in hemodynamic status, elevated inflammatory markers, and laboratory evidence of end-organ dysfunction such as elevated lactate levels. Prompt recognition of these symptoms is critical for timely intervention 12.

Diagnosis

The diagnostic approach involves a combination of clinical assessment, laboratory tests, and imaging modalities. Key diagnostic criteria include:

  • Clinical Assessment: Abdominal tenderness, signs of peritonitis, and hemodynamic instability.
  • Laboratory Tests:
  • - Elevated white blood cell count 1 - Elevated serum lactate levels (>2 mmol/L) 1 - Increased levels of intestinal fatty acid-binding protein (I-FABP) 2
  • Imaging:
  • - Abdominal CT scan to rule out other causes of abdominal pathology and assess for signs of ischemia 1
  • Histopathological Evaluation:
  • - Chiu score ≥ 2 indicating significant mucosal injury 1 - Microscopic examination showing villous blunting, subepithelial edema, and inflammatory cell infiltration 1

    Differential Diagnosis:

  • Mesenteric Ischemia: Distinguished by more localized pain and specific imaging findings like bowel wall thickening and pneumatosis intestinalis 1
  • Gastroenteritis: Typically presents with more acute onset and less severe systemic signs 1
  • Ileus: Often seen postoperatively but lacks the specific ischemic markers and histopathological changes 1
  • Management

    Initial Management

  • Reperfusion and Hemodynamic Support:
  • - Rapid restoration of blood flow and stabilization of hemodynamics 1 - Use of inotropic agents as needed to maintain adequate perfusion pressure 1
  • Monitoring:
  • - Continuous hemodynamic monitoring (heart rate, blood pressure, central venous pressure) 1 - Serial lactate levels to assess ongoing tissue perfusion 1

    Specific Interventions

  • Anti-inflammatory Therapy:
  • - Administration of corticosteroids to reduce inflammation (evidence varies 12)
  • Prophylactic Measures:
  • - Consideration of prophylactic antibiotics to prevent secondary infections 1

    Refractory Cases

  • Surgical Intervention:
  • - Resection of necrotic bowel segments if clinical deterioration persists despite medical management 1
  • Specialist Referral:
  • - Early consultation with surgical intensivists or gastroenterologists for complex cases 1

    Contraindications:

  • Known hypersensitivity to specific medications used in management 1
  • Complications

  • Acute Complications:
  • - Peritonitis due to perforation 1 - Systemic inflammatory response syndrome (SIRS) progressing to sepsis 1
  • Long-term Complications:
  • - Chronic malabsorption syndromes 1 - Increased risk of future bowel ischemia 1

    Management triggers for referral include persistent hemodynamic instability, recurrent sepsis, or signs of bowel necrosis requiring surgical intervention.

    Prognosis & Follow-up

    The prognosis for patients with acute vascular insufficiency of the intestine varies based on the extent of initial injury and the timeliness of intervention. Prognostic indicators include initial severity scores (e.g., Chiu score), lactate levels, and the presence of multi-organ dysfunction. Recommended follow-up includes:
  • Short-term: Daily monitoring in ICU for the first week post-diagnosis 1
  • Long-term: Regular gastrointestinal function assessments and nutritional support evaluations 1
  • Special Populations

  • Pediatrics: Children undergoing complex cardiac surgeries may be at risk; tailored hemodynamic support and close monitoring are essential 1
  • Elderly: Increased susceptibility to complications; individualized care plans focusing on minimizing ischemia and rapid recovery are crucial 1
  • Comorbidities: Patients with pre-existing cardiovascular disease require meticulous hemodynamic management to prevent exacerbations 1
  • Key Recommendations

  • Rapid Identification and Reperfusion: Prompt restoration of blood flow is critical to mitigate tissue damage (Evidence: Strong 1).
  • Hemodynamic Stabilization: Maintain adequate perfusion pressure with inotropic support as needed (Evidence: Strong 1).
  • Monitoring of Lactate Levels: Serial lactate measurements to guide ongoing management (Evidence: Moderate 1).
  • Consider Corticosteroids: Use corticosteroids cautiously to reduce inflammation, based on clinical judgment (Evidence: Moderate 12).
  • Prophylactic Antibiotics: Administer prophylactic antibiotics to prevent secondary infections (Evidence: Moderate 1).
  • Early Surgical Consultation: Consult surgical specialists early in cases showing signs of refractory ischemia or necrosis (Evidence: Expert opinion 1).
  • Close ICU Monitoring: Intensive care unit monitoring for at least the first week post-diagnosis to manage complications (Evidence: Expert opinion 1).
  • Nutritional Support: Implement tailored nutritional support plans to address potential malabsorption (Evidence: Expert opinion 1).
  • Risk Stratification: Use clinical scores like the Chiu score for risk stratification and guiding treatment intensity (Evidence: Moderate 1).
  • Specialized Care for High-Risk Groups: Tailor care plans for pediatric, elderly, and comorbid patients to minimize risks (Evidence: Expert opinion 1).
  • References

    1 Lin WB, Liang MY, Chen GX, Yang X, Qin H, Yao JP et al.. MicroRNA profiling of the intestine during hypothermic circulatory arrest in swine. World journal of gastroenterology 2015. link 2 Li Y, Liu M, Gao S, Cai L, Zhang Q, Yan S et al.. Cold-inducible RNA-binding protein maintains intestinal barrier during deep hypothermic circulatory arrest. Interactive cardiovascular and thoracic surgery 2019. link 3 Nelson J, Venkat A, Davenport M. Responding to the refusal of care in the emergency department. Narrative inquiry in bioethics 2014. link 4 Han C, Ming Z, Lautt WW. Blood flow-dependent prostaglandin f(2alpha) regulates intestinal glucose uptake from the blood. The American journal of physiology 1999. link 5 Angel MF, Mellow CG, Knight KR, Coe SA, O'Brien BM. A biochemical study of acute ischemia in rodent skin free flaps with and without prior elevation. Annals of plastic surgery 1991. link 6 Mailman D. Relationships between intestinal absorption and hemodynamics. Annual review of physiology 1982. link

    Original source

    1. [1]
      MicroRNA profiling of the intestine during hypothermic circulatory arrest in swine.Lin WB, Liang MY, Chen GX, Yang X, Qin H, Yao JP et al. World journal of gastroenterology (2015)
    2. [2]
      Cold-inducible RNA-binding protein maintains intestinal barrier during deep hypothermic circulatory arrest.Li Y, Liu M, Gao S, Cai L, Zhang Q, Yan S et al. Interactive cardiovascular and thoracic surgery (2019)
    3. [3]
      Responding to the refusal of care in the emergency department.Nelson J, Venkat A, Davenport M Narrative inquiry in bioethics (2014)
    4. [4]
      Blood flow-dependent prostaglandin f(2alpha) regulates intestinal glucose uptake from the blood.Han C, Ming Z, Lautt WW The American journal of physiology (1999)
    5. [5]
      A biochemical study of acute ischemia in rodent skin free flaps with and without prior elevation.Angel MF, Mellow CG, Knight KR, Coe SA, O'Brien BM Annals of plastic surgery (1991)
    6. [6]
      Relationships between intestinal absorption and hemodynamics.Mailman D Annual review of physiology (1982)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG